バイオバンク
研究業績
  1. Yagyu T, Ida K, Noguchi T. Serum Type III Procollagen Propeptide as a Potential Biomarker of Vascular Ehlers-Danlos Syndrome. Journal of the American College of Cardiology. 79, 1426-1427, 2022.
  2. Yoshimoto T, Tanaka K, Koge J, Saito S, Yamagami H, Nakaoku Y, Ogata S, Nishimura K, Yamaguchi E, Chiba T, Kawakami D, Shiozawa M, Kamogawa N, Ohta T, Satow T, Inoue M, Hattori Y, Washida K, Kataoka H, Chung JW, Bang OY, Toyoda K, Koga M, Maruyama H, Ihara M. Impact of the RNF213 p.R4810K Variant on Endovascular Therapy for Large‐Vessel Occlusion Stroke. Stroke: Vascular and Interventional Neurology. 2, e000396, 2022.
  3. Yamaguchi E, Yoshimoto T, Ogura S, Saito K, Saito S, Hattori Y, Wasida K, Nishimura K, Toyoda K, Koga M, Ihara M. Association of the RNF213 p.R4810K Variant With the Outer Diameter of Cervical Arteries in Patients With Ischemic Stroke. Stroke: Vascular and Interventional Neurology. 2, e000298, 2022.
  4. Hosoki S, Hattori Y, Saito S, Takegami M, Tonomura S, Yamamoto Y, Ikeda S, Hosomi N, Oishi N, Morita Y, Miyamoto Y, Nomura R, Nakano K, Ihara M. Risk Assessment of Cnm-Positive Streptococcus mutans in Stroke Survivors (RAMESSES): Protocol for a Multicenter Prospective Cohort Study. Frontiers in Neurology. 13, 816147, 2022.
  5. Saito S, Yamashiro T, Yamauchi M, Yamamoto Y, Noguchi M, Tomita T, Kawakami D, Shikata M, Tanaka T, Ihara M. Complement 3 Is a Potential Biomarker for Cerebral Amyloid Angiopathy. Journal of Alzheimer's Disease. 89, 381-387, 2022.
  6. Shimamoto K, Ohno S, Kato K, Takayama K, Sonoda K, Fukuyama M, Makiyama T, Okamura S, Asakura K, Imanishi N, Kato Y, Sakaguchi H, Kamakura T, Wada M, Yamagata K, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Kusano K, Horie M, Aiba T. Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1. Heart. 108, 840-847, 2022.
  7. Omae Y, Goto YI, Tokunaga K. National Center Biobank Network. Human Genome Variation. 9, 38, 2022.